ConductScience.org, home
Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk Open-label Extension
API referenceFor AI assistants

Trial · NCT02867813

Adverse events1,940

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

61 to 80 of 1,940

Download this page as JSON
TypeEventOrgan systemGroupAffectedAt riskEvents
seriousArrhythmiaCardiac disordersPlacebo in Parent Study02,532
seriousArrhythmiaCardiac disordersEvolocumab in Parent Study12,499
seriousArrhythmic stormCardiac disordersPlacebo in Parent Study12,532
seriousArrhythmic stormCardiac disordersEvolocumab in Parent Study02,499
seriousArteriosclerosis coronary arteryCardiac disordersPlacebo in Parent Study22,532
seriousArteriosclerosis coronary arteryCardiac disordersEvolocumab in Parent Study12,499
seriousAtrial fibrillationCardiac disordersPlacebo in Parent Study572,532
seriousAtrial fibrillationCardiac disordersEvolocumab in Parent Study472,499
seriousAtrial flutterCardiac disordersPlacebo in Parent Study112,532
seriousAtrial flutterCardiac disordersEvolocumab in Parent Study132,499
seriousAtrial tachycardiaCardiac disordersPlacebo in Parent Study02,532
seriousAtrial tachycardiaCardiac disordersEvolocumab in Parent Study12,499
seriousAtrioventricular blockCardiac disordersPlacebo in Parent Study12,532
seriousAtrioventricular blockCardiac disordersEvolocumab in Parent Study12,499
seriousAtrioventricular block completeCardiac disordersPlacebo in Parent Study92,532
seriousAtrioventricular block completeCardiac disordersEvolocumab in Parent Study92,499
seriousAtrioventricular block second degreeCardiac disordersPlacebo in Parent Study42,532
seriousAtrioventricular block second degreeCardiac disordersEvolocumab in Parent Study52,499
seriousBradycardiaCardiac disordersPlacebo in Parent Study82,532
seriousBradycardiaCardiac disordersEvolocumab in Parent Study92,499

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Previous pageNext page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02867813/events?page=4

API referenceFor AI assistants